The scale-up, promotion and use of oral pre-exposure prophylaxis (PrEP) in different settings and in different populations.

PrEP programmes and uptake: latest news

PrEP programmes and uptake resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales, Scotland and Northern Ireland, PrEP is available through NHS sexual health clinics.It...

    From: Factsheets

    Information level Level 2

PrEP programmes and uptake news from aidsmap

More news

PrEP programmes and uptake news selected from other sources

  • While The NHS Drags Its Heels On PrEP, This Is How Men Are Being Affected

    Although NHS England increased places in the PrEP Impact Trial to 13,000 participants in summer and recently said it hopes to extend this to 26,000 before 2020, it is yet to confirm when these places will become available – or what will happen when the three-year trial is up. Around 40% of trial clinics across England are currently turning away gay and bisexual men due to oversubscription, according to the Terrence Higgins Trust. Six men who’ve failed to access PrEP have told HuffPost UK the experience has left them feeling “depressed”, “anxious” and “frustrated”.

    12 February 2019 | Huffington Post
  • To Halt HIV, Advocates Push For PrEP Outreach To Black Women

    In 2013, not quite a year after the Food and Drug Administration approved the drug Truvada for HIV prevention, a coalition of 50 experts in HIV and women's health called on U.S. public health agencies to promote the pill and its approach, called pre-exposure prophylaxis, or PrEP, explicitly to women. Not much happened.

    11 February 2019 | NPR
  • What's Going On with the NHS PrEP Trial in England?

    NHS Engalnd delayed plans to fund doubling the trial in size, just days after its announcement – and that may leave people at even greater risk.

    04 February 2019 | Vice
  • “Nothing feels better than being confident that you are healthy” – a young man’s experience of PrEP

    PrEP recently became available in Ukraine, and for Georgii Onyschuk, a 29-year-old marketing professional from Kyiv, it has become a normal part of life as a young gay man.

    30 January 2019 | World Health Organization
  • For the greatest impact, end caps on PrEP access now

    NHS England continues to limit the roll-out of PrEP. Waiting until the Impact trial completes is reckless—for the greatest impact, make PrEP available now to all who need it.

    25 January 2019 | Lancet HIV (editorial)
  • HIV prevention gridlock as proposed extra NHS PrEP delayed

    A proposal to double the number of people able to access PrEP (a highly effective HIV prevention pill) through the PrEP Impact Trial has been delayed by the trial oversight board. This is despite the fact that NHS England has agreed to fund the additional 13,000 places. Currently, many clinics have no spaces for additional patients and are turning away people at high risk of HIV, some of whom are going on to acquire the virus.

    23 January 2019 | National AIDS Trust
  • PrEP IMPACT trial update – January 2019

    The PrEP Oversight Board met on 15th January 2019. The main item for discussion was a recommendation from the research team to increase trial places... Before final approval is given, the Board asked that rapid engagement with local authority commissioners and research sites be undertaken to assess their capacity to accept additional places... The Board will meet again within the next few weeks once these actions are complete, to confirm final decisions on increasing capacity, after which point additional places could then be allocated to participating clinics.

    23 January 2019 | NHS England
  • Council chiefs welcome decision to expand PrEP trial

    Local authority leaders have said they are 'pleased' with NHS England's decision to expand the trial of a drug that could 'significantly' reduce levels of HIV.

    15 January 2019 | LocalGov
  • NHS hope to double capacity of PrEP trial after huge demand for HIV prevention drug

    Deborah Gold, Chief Executive of NAT (National AIDS Trust), said: “Having been pushing for increased access to PrEP for so long, we are pleased that NHS England has listened to us and agreed to fund more spaces for PrEP patients on the Impact trial. It has been completely unacceptable to see people in need of PrEP being turned away from clinics."

    11 January 2019 | National AIDS Trust
  • NHS England announces support for doubling PrEP trial

    NHS England announced on Friday (11 January) its support for a request from researchers leading the PrEP IMPACT Trial. The request asks for the trial to double its places. This would give 26,000 people access to the life-saving pill, compared to the former 13,000 people.

    11 January 2019 | Gay Star News
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.